For healthcare professionals
Short-term pulse therapy with corticosteroids can be used to treat flare-ups of DED when symptoms aren’t controlled by other therapies8. Softacort® (0.335% hydrocortisone sodium phosphate, indicated for mild non-infectious conjunctival inflammation, is a low-risk9, effective option for Dry Eye flares with no significant effect9 on intraocular pressure (IOP). The SPC can be accessed here. Using Softacort® to treat flare-ups of conjunctival inflammation and then providing effective prevention with Théaloz® Duo can help to break the cycle of Dry Eye Disease.
Théaloz® Duo and Théaloz® Duo Gel lubricate and protect the ocular surface, reducing triggers such as increased osmolarity.
Adapted from Baudouin 20165